Showing results (1-10 of 90) with videos related to
Sort By:
Pageof 9
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|April 11, 2015
Chimeric antigen receptor-engineered T cells for the treatment of metastatic prostate cancerVictoria Hillerdal, Magnus EssandTrends in Immunology|August 15, 2025
News from the T cell trogocytosis frontStefano Barbera, Anna Dimberg, Magnus EssandImmunotherapy|December 22, 2016
Prospects to improve chimeric antigen receptor T-cell therapy for solid tumorsChuan Jin, Di Yu, Magnus EssandFrontiers of Hormone Research|August 26, 2015
Other Novel Therapies: Biomarkers, microRNAs and microRNA Inhibitors, DNA Methylation, Epigenetics, Immunotherapy and VirotherapyValeria Giandomenico, Chrissie Thirlwell, Magnus EssandSeminars in Cancer Biology|March 5, 2017
The cancer-immunity cycle as rational design for synthetic cancer drugs: Novel DC vaccines and CAR T-cellsMohanraj Ramachandran, Anna Dimberg, Magnus EssandThe Prostate|August 12, 2004
Generation of cytotoxic T lymphocytes specific for the prostate and breast tissue antigen TARPBjörn Carlsson, Thomas H Tötterman, Magnus EssandBJU International|September 8, 2005
The immunotherapy of prostate and bladder cancerThomas H Totterman, Angelica Loskog, Magnus EssandBMC Cancer|January 21, 2014
Systemic treatment with CAR-engineered T cells against PSCA delays subcutaneous tumor growth and prolongs survival of miceVictoria Hillerdal, Mohanraj Ramachandran, Justyna Leja, et al.Pageof 9